• Okadaic acid: PP1/PP2A Workflow Guide

  2026-08-27

  Okadaic acid provides a controlled way to inhibit PP2A preferentially at low nanomolar exposure and to inhibit PP1 at higher exposure, supporting phosphorylation-dependent signaling and apoptosis studies. It is appropriate for defined biochemical or cell-based experiments with matched controls, but should not be treated as a broad phosphatase inhibitor or assigned a universal cell-treatment dose.

• Olsalazine Sodium Research Workflows

  2026-08-27

  Olsalazine Sodium supports reproducible inflammation, colorectal cancer, and xenobiotic-clearance experiments when its aqueous solubility and prodrug biology are handled deliberately. This guide connects tumor apoptosis induction and LTB4 chemotaxis assays with a recent mosquito transport study, providing practical setup, controls, and troubleshooting decisions.

• Topotecan (SKF104864) in Replication-Stress Research

  2026-08-26

  Topotecan (SKF104864) converts topoisomerase I activity into a controllable replication-stress challenge for tumor-cell, glioma, and DNA-repair assays. This workflow connects dose-response phenotyping with Dna2-dependent genome-maintenance studies while emphasizing practical controls, timing, and troubleshooting.

• BIRC2 and BIRC3 Regulation in Lung Epithelium

  2026-08-26

  The reference study distinguishes how inflammatory cytokines and glucocorticoids regulate the related inhibitor-of-apoptosis genes BIRC2 and BIRC3 in pulmonary epithelial models. Its comparison of cell lines with primary bronchial epithelium shows that BIRC3 is strongly inducible and glucocorticoid-responsive, whereas BIRC2 is comparatively constitutive, providing a framework for interpreting epithelial inflammatory and survival responses.

• Cy3-UTP for Fluorescent RNA Workflows

  2026-08-25

  Cy3-UTP enables direct fluorescent RNA labeling during in vitro transcription, supporting RNA imaging, binding assays, and sensitive detection workflows. This guide combines practical optimization steps with a careful comparison to CRISPR-based live-cell chromatin imaging.

• Standardized Whole-Blood Stimulation in Immunometabolism

  2026-08-25

  Zhao and colleagues present a standardized whole-blood stimulation protocol that combines innate immune challenges with targeted metabolic interventions and cytokine measurement. The workflow preserves the physiological complexity of blood while enabling cohort-scale analysis of how metabolic pathways selectively shape immune responses.

• TBK1, Microglial Pyroptosis, and Diabetic Neuropathy

  2026-08-24

  Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic driver of painful diabetic neuropathy by linking its activation in spinal microglia to NF-κB signaling, NLRP3 inflammasome activity, and pyroptosis. Their combination of genetic knockdown, pharmacological inhibition, behavioral testing, and tissue profiling provides a framework for studying neuroinflammation as a therapeutic axis in diabetic pain.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-24

  Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR inhibitors at substantially lower concentrations than a wild-type yeast background. The system identified concentration-dependent activity for established inhibitors and aminophylline, while finding no evidence of TOR inhibition for several tested compounds, including nebivolol, illustrating both the platform’s screening value and its assay-specific limitations.

• CFDA-SE for Cell Proliferation Tracking

  2026-08-23

  CFDA-SE, also called Carboxyfluorescein diacetate succinimidyl ester, is a cell-permeable fluorescent labeling reagent that converts intracellular esterase activity into a durable signal. Its generation-dependent fluorescence loss supports flow-cytometric analysis of lymphocyte, fibroblast, natural killer cell, and bacterial proliferation.

• AM 281 in CB1 Neuropharmacology Workflows

  2026-08-22

  AM 281 provides a high-affinity way to interrogate CB1 signaling, from receptor assays to astrocyte GLT-1 and cognitive dysfunction models. This workflow-focused guide connects compound handling, time-resolved TBI experiments, behavioral readouts, and troubleshooting for more interpretable neuropharmacology data.

• Smoothened Function in Honeybee Olfaction

  2026-08-22

  Guo et al. characterize Smoothened (Smo) in Apis mellifera and connect antenna-enriched expression with olfactory receptor transcription, electroantennographic responses, and odor-guided behavior. The study provides integrated evidence that Hedgehog pathway activity may contribute to insect olfactory regulation, while also highlighting the need for species- and tissue-specific validation of pharmacological Smo perturbation.

• Levofloxacin in Resistance and Cell Assays

  2026-08-21

  Levofloxacin is a synthetic fluoroquinolone antibiotic with value beyond routine antibacterial testing. This article connects DNA gyrase inhibition with resistance-transmission studies and carefully controlled osteoblast and chondrocyte assays.

• Phytol, RXR Signaling, and Translational Assay Design

  2026-08-20

  Phytol offers translational researchers a distinctive combination of retinoid X receptor activity, metabolic context, and GABAergic effects. This article presents a mechanistic framework for validating Phytol and trans-Phytol, managing formulation and isomer-related variables, and designing more informative assays without overstating preclinical evidence.

• Mouse Tissue Lysis Kit (K1038): Direct PCR Guide

  2026-08-20

  The Mouse Tissue Lysis Kit (K1038) prepares mouse tissue lysates for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and genetic mutation detection workflows, not for diagnostic or medical use.

• TNF-alpha Recombinant Murine Protein: Assay Design

  2026-08-19

  Discover how TNF-alpha recombinant murine protein can be used to separate TNF receptor signaling from transcription-linked cell death. This guide integrates product specifications with the 2025 Cell study of Pol II degradation-dependent apoptosis to improve assay interpretation.

8046 records 1/537 page Next 12345 下5页 Last page